You are here

activists

Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access

Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access

Fierce Pharma

Bristol Myers Squibb

Gilead Sceinces

Flag link:

Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics

Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics

Fierce Pharma

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Activist investor snaps Mereo's olive branch as proxy feud looms

Activist investor snaps Mereo's olive branch as proxy feud looms

Fierce Biotech

Mereo BioPharma

Flag link:

Radius, fending off activists, outlines pitch for $890 million buyout

Radius, fending off activists, outlines pitch for $890 million buyout

BioPharma Dive

Flag link:

Walmsley Targeted Again as Activists Renew Plea for New GSK CEO

Walmsley Targeted Again as Activists Renew Plea for New GSK CEO

BioSpace

Flag link:

Ziopharm and a minority investor spent Thanksgiving fighting over control of the company as activist attack continues to unfold

Ziopharm and a minority investor spent Thanksgiving fighting over control of the company as activist attack continues to unfold

Endpoints

Ziopharm Oncology

Flag link:

(Another) activist attack on Alexion, as Paul Singer-founded hedge fund calls for biotech to sell itself

(Another) activist attack on Alexion, as Paul Singer-founded hedge fund calls for biotech to sell itself

Endpoints

Flag link:

Activists seek to block a Gilead patent extension on a lucrative HIV drug

Activists seek to block a Gilead patent extension on a lucrative HIV drug

Stat

Gilead Sciences

Flag link:

At a rally outside PhRMA’s headquarters, activists accuse drug makers of blocking ‘Medicare for All’

At a rally outside PhRMA’s headquarters, activists accuse drug makers of blocking ‘Medicare for All’

Stat

Medicare for All

Flag link:

Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan

Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan

Endpoints

Flag link:

Protesters’ goodbye for Scott Gottlieb: a supersized heroin spoon and claims FDA did too little on opioids

Protesters’ goodbye for Scott Gottlieb: a supersized heroin spoon and claims FDA did too little on opioids

Stat

Flag link:

What do Allergan activists really want? A new CEO to replace Saunders, analyst says

What do Allergan activists really want? A new CEO to replace Saunders, analyst says

Fierce Pharma

Flag link:

As Alzheimer’s drug developers give up on today’s patients, where is the outrage?

As Alzheimer’s drug developers give up on today’s patients, where is the outrage?

Stat

Alzheimer's disease

Flag link:

Sarepta Therapeutics May Attract Activist Attention

Sarepta Therapeutics May Attract Activist Attention

TheStreet.com

Sarepta Therapeutics

Flag link:

Stada Delays Annual Meeting as Activist Battle Escalates

Stada Delays Annual Meeting as Activist Battle Escalates

Bloomberg

Flag link:

Why Depomed Is Rising on Activist Pressure

Why Depomed Is Rising on Activist Pressure

24/7 Wall St

Flag link:

Blacklisting Icahn: How Some Drug Companies Keep Out Activists

Blacklisting Icahn: How Some Drug Companies Keep Out Activists

Bloomberg

Endo International

Teva Pharmaceutical

Flag link:

Activists want Ariad's CEO out the door, report says

Activists want Ariad's CEO out the door, report says

Fierce Biotech

Ariad Pharmaceuticals

Flag link:

Merck execs' bogeymen: Animal-rights, disease activists, plus laid-off workers

Merck execs' bogeymen: Animal-rights, disease activists, plus laid-off workers

Fierce Pharma

Flag link:

Swiss activists plan 'occupy' protest at Novartis chair's house

Swiss activists plan 'occupy' protest at Novartis chair's house

Fierce Pharma

Flag link:

Pages